Thrombospondin-4 (TSP4) gene-modified bone marrow stromal cells (BMSCs) promote the effect of therapeutic angiogenesis in critical limb ischemia (CLI) of diabetic rats

Qian Zhang,Tao Wang,Xiangfeng Wu,Ying Wang,Xuanqin Wu,Meiling Zhou,Zhu Li,Bing Liu,Feng Zheng,Xizhuo Sun,Tao Liu
DOI: https://doi.org/10.1016/j.bbrc.2020.06.148
IF: 3.1
2020-11-01
Biochemical and Biophysical Research Communications
Abstract:<p>Critical limb ischemia (CLI) is the leading cause of lower limb amputation. Traditional treatments for CLI have limitations. Studies have shown that thrombospondin-4 (TSP4) can promote the growth of neovascularization. In this study, we observed the angiogenesis efficiency of TSP4-overexpressing BMSC transplantation in CLI treatment. The recombinant <em>FT106-tsp4-gfp</em> lentiviral vector plasmid was constructed and transfected into 293FT cells. Primary BMSCs were successfully infected with the <em>tsp4</em> virus, and TSP4 overexpression was confirmed before TSP4-BMSCs infusion. A rat CLI model was established, and 60 CLI rats were randomly divided into the CLI, BMSC + CLI and TSP4-BMSC + CLI groups. The effect of TSP4-BMSC on angiogenesis was detected by the motor function, immunohistochemistry and immunofluorescence staining assays. Neovascular density was detected by digital subtraction angiography (DSA). Our results demonstrated that TSP4-BMSCs improved the motor function score of the CLI rats and increased MMP2, MMP9, Ang-1, VEGF and vWF protein expression in tissue of the ischaemic area. Meanwhile, new blood vessels can be observed around the ischemic area after TSP4-BMSCs treatment. Our data illustrate that TSP4-BMSCs can promote the recovery of motor function in diabetic hind limb ischaemic rats. TSP4-BMSCs have better therapeutic effects than BMSCs.</p>
biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?